For citations:
Bugaeva L.I., Sirotenko V.S., Spasov A.A., Kucheryavenko A.F., Lebedeva S.A., Denisova T.D., Maltsev M.V., Getmanenko A.Yu., Korzhova T.M., Lavrova E.B., Melikhova N.S. Preclinical study of the safety aspects of the substance of a new benzimidazole derivative with an antithrombotic effect during the course administration of the substance to rats. Toxicological Review. 2024;32(2):115-126. (In Russ.) https://doi.org/10.47470/0869-7922-2024-32-2-115-126
Email this article 